Also trades as: 0KHE.L (LSE) · $vol 0M
RVTY NYSE
Revvity, Inc.
1W: +0.3%
1M: +15.7%
3M: +34.2%
YTD: +54.5%
1Y: +65.3%
3Y: +39.8%
5Y: -16.3%
$151.53
+2.47 (+1.66%)
Weekly Expected Move ±6.8%
$131
$141
$152
$162
$172
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.60
Bullish
2 bullish
1 neutral
0 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (100)
Moderna, Illumina lead healthcare gains in September as medtech drags
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection
Revvity Inc. $RVTY Shares Acquired by State Street Corp
Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus
Revvity slips as CFRA downgrades on limited near-term upside
Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?
Stock futures mixed as Fed rate decision takes center stage
Revvity extends gains with another 9% advance, sets new high
Revvity Inc. $RVTY Shares Acquired by California State Teachers Retirement System
Amundi Trims Holdings in Revvity Inc. $RVTY
Revvity to Acquire Human Cell Design to Boost Metabolic Discovery
Why Revvity (RVTY) is a Top Momentum Stock for the Long-Term
Revvity to acquire Human Cell Design
Hsbc Holdings PLC Has $19.76 Million Position in Revvity Inc. $RVTY
Notable healthcare headlines for the week: UnitedHealth, Moderna, and Medtronic in focus
Empowered Funds LLC Acquires New Position in Revvity Inc. $RVTY
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks
Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?
What Makes Revvity (RVTY) a New Buy Stock
Notable healthcare headlines for the week: Veeva Systems, Boston Scientific in focus
Bank of New York Mellon Corp Invests $78.77 Million in Revvity Inc. $RVTY
Bank of New York Mellon Corp Invests $78.77 Million in Revvity Inc. $RVTY
Is the Options Market Predicting a Spike in Revvity Stock?
Assenagon Asset Management S.A. Has $1.72 Million Stock Position in Revvity Inc. $RVTY
Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs
Revvity Inc. $RVTY Shares Acquired by Cetera Investment Advisers
Revvity (RVTY) Q2 2026 Earnings Call Transcript
RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up
Revvity (RVTY) Q2 Earnings and Revenues Surpass Estimates
Revvity beats top-line and bottom-line estimates; updates FY26 outlook
Here are the major earnings before the open Tuesday
Revvity to Report Q2 Earnings: What's in Store for the Stock?
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Bank of Nova Scotia Has $5.13 Million Stock Position in Revvity Inc. $RVTY
Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs
Revvity to Launch Signals for Startups for Emerging Biotech Companies
Revvity Expands Signals AI With Anthropic Claude Integration
Revvity Launches Signals AI to Advance Scientific R&D Workflows
Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report?
Notable healthcare headlines for the week: UnitedHealthcare, Pfizer, Eli Lilly in focus
Stock futures rise on hopes of U.S.-Iran conflict resolution
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay
Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus
Most healthcare companies report higher Y/Y EPS in strong earnings week
Revvity (RVTY) Q1 2026 Earnings Transcript
Revvity outlines 3%-4% 2026 organic growth and $5.20-$5.30 EPS while planning China immunodiagnostics divestiture
RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution
Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics
Revvity (RVTY) Q1 Earnings and Revenues Top Estimates
Earnings Scheduled For May 5, 2026
Revvity beats top-line and bottom-line estimates; updates FY26 outlook
Revvity Q1 2026 Earnings Preview
Revvity to Report Q1 Earnings: What's in Store for the Stock?
Packaging Corp Of America To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Revvity Inc. $RVTY Position Trimmed by Asset Management One Co. Ltd.
KBC Group NV Grows Stock Holdings in Revvity Inc. $RVTY
Sumitomo Mitsui Trust Group Inc. Has $3.46 Million Stock Position in Revvity Inc. $RVTY
RVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D Data
Revvity Gains on Diagnostics Strength, Faces China Headwinds
Allspring Global Investments Holdings LLC Raises Holdings in Revvity Inc. $RVTY
Barclays PLC Sells 37,149 Shares of Revvity Inc. $RVTY
Dimensional Fund Advisors LP Purchases 596,436 Shares of Revvity Inc. $RVTY
Revvity Inc. $RVTY Stock Position Lifted by Elo Mutual Pension Insurance Co
Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report?
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Citigroup Inc. Has $6.58 Million Stock Position in Revvity Inc. $RVTY
Stock index futures slide amid renewed tariff-related uncertainity
Revvity to Present at Upcoming Investor Conferences
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026
Revvity: Close To A Buy, Not Quite There
Here's Why Revvity (RVTY) is a Strong Momentum Stock
Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results
Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic Growth Initiatives
Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript
Revvity's Strong Performance Overshadowed by Market Uncertainty
Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates
Revvity (RVTY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025
Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?
Curious about Revvity (RVTY) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Revvity Board Declares Quarterly Dividend
Revvity (RVTY) Earnings Expected to Grow: Should You Buy?
Universal Beteiligungs und Servicegesellschaft mbH Sells 24,911 Shares of Revvity Inc. $RVTY
Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Campbell & CO Investment Adviser LLC Purchases New Holdings in Revvity Inc. $RVTY
Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Revvity Stock Jumps on Profit Outlook Hike. Why the Shares Are at a Crossroads.
Revvity says it will exceed 2025 profit forecast range
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance
RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models
Revvity Inc. $RVTY Shares Purchased by SG Americas Securities LLC
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
Revvity (NYSE:RVTY) and InnovAge (NASDAQ:INNV) Financial Analysis